Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of real-world data (RWD) analysis on efficacy and post-progression outcomes with pembrolizumab plus chemo vs chemo alone in metastatic non-squamous non-small cell lung cancer with PD-L1 < 50.
Attili I, Valenza C, Santoro C, Antonarelli G, Trillo Aliaga P, Del Signore E, Catania C, Spitaleri G, Passaro A, de Marinis F. Attili I, et al. Among authors: valenza c. Front Oncol. 2022 Aug 10;12:980765. doi: 10.3389/fonc.2022.980765. eCollection 2022. Front Oncol. 2022. PMID: 36033444 Free PMC article.
Emerging treatment landscape of non-muscle invasive bladder cancer.
Valenza C, Antonarelli G, Giugliano F, Aurilio G, Verri E, Briganti A, Curigliano G, Necchi A. Valenza C, et al. Expert Opin Biol Ther. 2022 Jun;22(6):717-734. doi: 10.1080/14712598.2022.2082869. Epub 2022 May 31. Expert Opin Biol Ther. 2022. PMID: 35634893 Review.
Immune-Related Adverse Event Likelihood Score Identifies "Pure" IRAEs Strongly Associated With Outcome in a Phase I-II Trial Population.
Mazzarella L, Giugliano F, Nicolo E, Esposito A, Crimini E, Tini G, Uliano J, Corti C, D'Amico P, Aliaga PT, Valenza C, Repetto M, Antonarelli G, Ascione L, Vivanet G, Berton Giachetti P, Minchella I, Belli C, Locatelli M, Criscitiello C, Curigliano G. Mazzarella L, et al. Among authors: valenza c. Oncologist. 2024 Feb 2;29(2):e266-e274. doi: 10.1093/oncolo/oyad239. Oncologist. 2024. PMID: 37715957 Free PMC article.
Treatment optimization in early triple negative breast cancer.
Kotteas E, Bielo LB, Valenza C, Santoro C, Koukoutzeli C, Trapani D, Curigliano G. Kotteas E, et al. Among authors: valenza c. Expert Rev Anticancer Ther. 2023 Jul-Dec;23(10):1107-1116. doi: 10.1080/14737140.2023.2268840. Epub 2023 Oct 26. Expert Rev Anticancer Ther. 2023. PMID: 37873652 Review.
Biomarkers for Antibody-Drug Conjugates in Solid Tumors.
Katrini J, Boldrini L, Santoro C, Valenza C, Trapani D, Curigliano G. Katrini J, et al. Among authors: valenza c. Mol Cancer Ther. 2024 Apr 2;23(4):436-446. doi: 10.1158/1535-7163.MCT-23-0482. Mol Cancer Ther. 2024. PMID: 38363729 Review.
41 results